Faculty Opinions recommendation of Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure.

2021 ◽  
Author(s):  
WH Wilson Tang
Keyword(s):  
Heart Failure ◽  
Systolic Heart Failure ◽  
Cardiac Myosin ◽  
Omecamtiv Mecarbil

scholarly journals Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure

2020 ◽  
Author(s):  
John R. Teerlink ◽  
Rafael Diaz ◽  
G. Michael Felker ◽  
John J.V. McMurray ◽  
Marco Metra ◽  
...  
Keyword(s):  
Heart Failure ◽  
Systolic Heart Failure ◽  
Cardiac Myosin ◽  
Omecamtiv Mecarbil

scholarly journals Omecamtiv mecarbil: a promising new drug in systolic heart failure

2012 ◽  
Vol 14 (3) ◽  
pp. 232-233 ◽  
Author(s):  
Matthijs F.L. Meijs ◽  
Folkert W. Asselbergs ◽  
Pieter A. Doevendans
Keyword(s):  
Heart Failure ◽  
Systolic Heart Failure ◽  
New Drug ◽  
Omecamtiv Mecarbil
Sign in / Sign up

Export Citation Format

Share Document